Ball & Co Wealth Management
ABBV icon

Ball & Co Wealth Management’s AbbVie ABBV Stock Holding History

Ball & Co Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$598K Buy
2,287
+15
+0.7% +$3.84K 0.41% 19
2026
Q2 		$571K Buy
2,272
+19
+0.8% +$4.09K 0.4% 17
2026
Q1 		$490K Buy
2,253
+16
+0.7% +$3.55K 0.41% 15
2025
Q4 		$511K Sell
2,237
-34
-1% -$7.74K 0.33% 22
2025
Q3 		$525K Buy
2,271
+18
+0.8% +$3.66K 0.35% 20
2025
Q2 		$418K Buy
2,253
+20
+0.9% +$3.72K 0.45% 14
2025
Q1 		$467K Buy
2,233
+19
+0.9% +$3.69K 0.5% 14
2024
Q4 		$393K Buy
+2,214
New +$407K 0.31% 14

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Ball & Co Wealth Management's ABBV Position: Q3 2026 in Review

Ball & Co Wealth Management increased its AbbVie (ABBV) stake by 0.66% in Q3 2026, buying an estimated $3.84K and bringing the position to 2,287 shares worth $598K. The position accounts for 0.41% of the portfolio, ranked #19.

Ball & Co Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 3,064 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Ball & Co Wealth Management held 2,287 shares of AbbVie worth $598K as of Q3 2026.
  • Ball & Co Wealth Management bought 15 AbbVie shares in Q3 2026, an estimated $3.84K.
  • AbbVie made up 0.41% of Ball & Co Wealth Management's portfolio in Q3 2026, its #19 holding.
  • Ball & Co Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 3,064 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Ball & Co Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.